Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2007-04-12 21:14:39 UTC |
---|
Update Date | 2022-03-07 02:49:29 UTC |
---|
HMDB ID | HMDB0006048 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Bolasterone |
---|
Description | Bolasterone is an anabolic androgenic steroid. Analysis of steroids in urine has been used to detect different hormonal actions in human beings such as testicular function in men, hyperandrogenic disorders in women and puberty problems in children, by the measurement of anabolic steroids, and some hormonal disorders such as adrenocortical adenoma and Cushing syndrome by the control of corticoids. This steroid have been included in the International Olympic Committee (IOC) doping list due to their illegal use in some sports and in the list of schedules drugs in several countries because of its use by young people. In addition, the examination of endogenous steroids profile provides information about the health and the use of exogenous steroids. Bolasterone is excreted as the original compound in human urine. Androgenic anabolic steroids (AAS) are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. The use of anabolic steroids was banned by the International Olympic Committee for the first time at the Olympic Games in Montreal in 1976. Since that time the misuse of anabolic steroids by athletes has been controlled by analysis of urine of the excreted steroids or their metabolites, or both. (PMID: 10892583 , 10932808 , 14976846 , 15042372 , 15231229 , 3308301 , 8456050 , 8674183 , 16040239 ). |
---|
Structure | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](C)CC2=CC(=O)CC[C@]12C InChI=1S/C21H32O2/c1-13-11-14-12-15(22)5-8-19(14,2)16-6-9-20(3)17(18(13)16)7-10-21(20,4)23/h12-13,16-18,23H,5-11H2,1-4H3/t13-,16+,17+,18-,19+,20+,21+/m1/s1 |
---|
Synonyms | Value | Source |
---|
7alpha,17alpha-Dimethyltestosterone | Kegg | 17beta-Hydroxy-7alpha,17-dimethylandrost-4-en-3-one | Kegg | U19763 | Kegg | 7a,17a-Dimethyltestosterone | Generator | 7Α,17α-dimethyltestosterone | Generator | 17b-Hydroxy-7a,17-dimethylandrost-4-en-3-one | Generator | 17Β-hydroxy-7α,17-dimethylandrost-4-en-3-one | Generator | (7a,17b)-17-Hydroxy-7,17-dimethyl-androst-4-en-3-one | HMDB | 17b-Hydroxy-7a,17-dimethyl-androst-4-en-3-one | HMDB | 17b-Hydroxy-7a,17a-dimethylandrost-4-ene-3-one | HMDB | 7a,17-Dimethyl-testosterone | HMDB | 7a,17a-Dimethyl-17b-hydroxyandrost-4-en-3-one | HMDB | Myagen | HMDB |
|
---|
Chemical Formula | C21H32O2 |
---|
Average Molecular Weight | 316.4776 |
---|
Monoisotopic Molecular Weight | 316.240230268 |
---|
IUPAC Name | (1S,2R,9R,10R,11S,14S,15S)-14-hydroxy-2,9,14,15-tetramethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one |
---|
Traditional Name | bolasterone |
---|
CAS Registry Number | 1605-89-6 |
---|
SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](C)CC2=CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C21H32O2/c1-13-11-14-12-15(22)5-8-19(14,2)16-6-9-20(3)17(18(13)16)7-10-21(20,4)23/h12-13,16-18,23H,5-11H2,1-4H3/t13-,16+,17+,18-,19+,20+,21+/m1/s1 |
---|
InChI Key | IVFYLRMMHVYGJH-VLOLGRDOSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- Hydroxysteroid
- Oxosteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Tertiary alcohol
- Cyclic alcohol
- Ketone
- Cyclic ketone
- Organooxygen compound
- Alcohol
- Carbonyl group
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 164 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Bolasterone,1TMS,isomer #1 | C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C)[C@@H]21 | 2816.3 | Semi standard non polar | 33892256 | Bolasterone,1TMS,isomer #2 | C[C@@H]1CC2=CC(O[Si](C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21 | 2688.8 | Semi standard non polar | 33892256 | Bolasterone,2TMS,isomer #1 | C[C@@H]1CC2=CC(O[Si](C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C)[C@@H]21 | 2747.6 | Semi standard non polar | 33892256 | Bolasterone,2TMS,isomer #1 | C[C@@H]1CC2=CC(O[Si](C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C)[C@@H]21 | 2787.3 | Standard non polar | 33892256 | Bolasterone,2TMS,isomer #1 | C[C@@H]1CC2=CC(O[Si](C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C)[C@@H]21 | 2854.2 | Standard polar | 33892256 | Bolasterone,1TBDMS,isomer #1 | C[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C(C)(C)C)[C@@H]21 | 3052.8 | Semi standard non polar | 33892256 | Bolasterone,1TBDMS,isomer #2 | C[C@@H]1CC2=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21 | 2958.6 | Semi standard non polar | 33892256 | Bolasterone,2TBDMS,isomer #1 | C[C@@H]1CC2=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C(C)(C)C)[C@@H]21 | 3263.7 | Semi standard non polar | 33892256 | Bolasterone,2TBDMS,isomer #1 | C[C@@H]1CC2=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C(C)(C)C)[C@@H]21 | 3250.2 | Standard non polar | 33892256 | Bolasterone,2TBDMS,isomer #1 | C[C@@H]1CC2=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O[Si](C)(C)C(C)(C)C)[C@@H]21 | 3074.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Bolasterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f79-0292000000-d45cc06905f97c71acb7 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bolasterone GC-MS (1 TMS) - 70eV, Positive | splash10-00di-1219000000-a3d8e93a3429c1b5b79e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bolasterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 10V, Negative-QTOF | splash10-014i-0029000000-6f88574915ba36904ede | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 20V, Negative-QTOF | splash10-014i-0059000000-88ccda88856d7b515ee6 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 40V, Negative-QTOF | splash10-00kb-0090000000-6f3e258701147d991147 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 10V, Negative-QTOF | splash10-014i-0009000000-be6e06313d0abca8e664 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 20V, Negative-QTOF | splash10-014i-0009000000-be6e06313d0abca8e664 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 40V, Negative-QTOF | splash10-014i-0097000000-3e67e2b99b64bbb19dde | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 10V, Positive-QTOF | splash10-00kb-0095000000-24b926788859812bd140 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 20V, Positive-QTOF | splash10-00kb-0291000000-d17e4bd109b597541b52 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 40V, Positive-QTOF | splash10-0zi9-3490000000-b1ee70c1893fd95ab783 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 10V, Positive-QTOF | splash10-014i-0749000000-4e378b170e7e0e501a17 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 20V, Positive-QTOF | splash10-002f-3911000000-3d55560ae9987134faeb | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bolasterone 40V, Positive-QTOF | splash10-000f-0900000000-1206f2feee3fa74b8674 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Hungerford NL, Sortais B, Smart CG, McKinney AR, Ridley DD, Stenhouse AM, Suann CJ, Munn KJ, Sillence MN, McLeod MD: Analysis of anabolic steroids in the horse: development of a generic ELISA for the screening of 17alpha-alkyl anabolic steroid metabolites. J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):317-34. [PubMed:16040239 ]
- Yesalis CE, Bahrke MS: Doping among adolescent athletes. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):25-35. [PubMed:10932808 ]
- Furlanello F, Bentivegna S, Cappato R, De Ambroggi L: Arrhythmogenic effects of illicit drugs in athletes. Ital Heart J. 2003 Dec;4(12):829-37. [PubMed:14976846 ]
- Bricout V, Wright F: Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances? Eur J Appl Physiol. 2004 Jun;92(1-2):1-12. Epub 2004 Mar 20. [PubMed:15042372 ]
- Foster ZJ, Housner JA: Anabolic-androgenic steroids and testosterone precursors: ergogenic aids and sport. Curr Sports Med Rep. 2004 Aug;3(4):234-41. [PubMed:15231229 ]
- Hatton CK, Catlin DH: Detection of androgenic anabolic steroids in urine. Clin Lab Med. 1987 Sep;7(3):655-68. [PubMed:3308301 ]
- Brower KJ: Anabolic steroids. Psychiatr Clin North Am. 1993 Mar;16(1):97-103. [PubMed:8456050 ]
- Schanzer W: Metabolism of anabolic androgenic steroids. Clin Chem. 1996 Jul;42(7):1001-20. [PubMed:8674183 ]
- Gonzalo-Lumbreras R, Izquierdo-Hornillos R: Optimization of the high-performance liquid chromatographic separation of a complex mixture containing urinary steroids, boldenone and bolasterone: application to urine samples. J Chromatogr B Biomed Sci Appl. 2000 May 26;742(1):47-57. [PubMed:10892583 ]
|
---|